Vishay Intertechnology (NYSE: VSH) grows Q1 2026 sales but free cash turns negative
Vishay Intertechnology reports stronger results for the fiscal quarter ended April 4, 2026. Net revenues rose to $839.2 million from $715.2 million a year earlier, driven mainly by higher sales volumes across segments and regions. Gross profit margin improved to 21.0%, up from 19.0%, as better factory utilization and efficiencies outweighed higher metals and materials costs.
The company returned to profitability, posting net earnings of $7.2 million, or $0.05 per diluted share, compared with a loss of $4.1 million, or $(0.03) per share, in the prior-year quarter. Operating cash flow increased to $63.7 million, but heavy capital expenditures of $110.7 million led to negative free cash of $46.9 million as Vishay continues its multiyear capacity expansion, including a planned $400–$440 million capital spend in 2026 and major investment in a 12-inch wafer fab in Itzehoe, Germany.
By segment, all major product lines grew revenue year over year, with notable contributions from Resistors, Capacitors, Diodes, and MOSFETs. Segment operating income rose to $118.8 million from $83.5 million, while consolidated operating margin remained modest at 2.6% due to higher selling, general, and administrative expenses tied to strategic initiatives and stock-based compensation. Backlog climbed to $1.59 billion and the book-to-bill ratio reached 1.34, signaling continued demand momentum.
Positive
- None.
Negative
- None.
Insights
Vishay is in an upturn with broad-based growth, but heavy capex keeps free cash negative near term.
Vishay Intertechnology delivered a solid rebound with net revenues of $839.2 million, up 17.3% year over year, and gross margin rising to 21.0%. Every major segment grew revenue versus the prior-year quarter, and segment operating income increased to $118.8 million, showing healthier underlying operations.
The company is deliberately accepting near-term cash pressure to fund capacity expansion. Operating cash flow reached $63.7 million, but capital expenditures of $110.7 million produced negative free cash of $46.9 million. Management still plans $400–$440 million in 2026 capex, with about half earmarked for a 12-inch wafer fab in Itzehoe, Germany, and continues restructuring to optimize its manufacturing footprint.
Leverage is manageable but higher, with total debt of $983.1 million and net cash and short-term investments at $(503.5) million. Backlog of $1.59 billion and a book-to-bill ratio of 1.34 suggest demand support for this investment cycle, but actual returns will depend on execution of the fab projects and sustained orders across automotive, industrial, and other end markets.
Key Figures
Key Terms
free cash financial
segment operating income financial
book-to-bill ratio financial
Stockholder Return Policy financial
convertible senior notes financial
cash conversion cycle financial
|
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
|
|
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
|
|
|
||
|
(State or Other Jurisdiction of Incorporation)
|
(I.R.S. Employer Identification Number)
|
|
|
|
|
|
|
(Address of Principal Executive Offices)
|
(Registrant’s Area Code and Telephone Number)
|
|
Title of each class
|
Trading symbol
|
Name of exchange on which registered
|
||
|
|
Accelerated filer ☐
|
|
|
Non-accelerated filer ☐
|
Smaller reporting company
|
|
|
Emerging growth company
|
|
Page Number
|
||||
|
PART I.
|
FINANCIAL INFORMATION
|
|||
|
Item 1.
|
Financial Statements (Unaudited)
|
|||
|
Consolidated Condensed Balance Sheets – April 4, 2026 and December 31, 2025
|
4
|
|||
|
Consolidated Condensed Statements of Operations – Fiscal Quarters Ended April 4, 2026 and March 29, 2025
|
6
|
|||
|
Consolidated Condensed Statements of Comprehensive Income – Fiscal Quarters Ended April 4, 2026 and March 29, 2025
|
7
|
|||
|
Consolidated Condensed Statements of Cash Flows – Three Fiscal Months Ended April 4, 2026 and March 29, 2025
|
8
|
|||
|
Consolidated Condensed Statements of Equity
|
9
|
|||
|
Notes to Consolidated Condensed Financial Statements
|
10
|
|||
|
Item 2.
|
Management’s Discussion and Analysis of Financial Condition and Results of Operations
|
21
|
||
|
Item 3.
|
Quantitative and Qualitative Disclosures About Market Risk
|
39
|
||
|
Item 4.
|
Controls and Procedures
|
39
|
||
|
PART II.
|
OTHER INFORMATION
|
|||
|
Item 1.
|
Legal Proceedings
|
40
|
||
|
Item 1A.
|
Risk Factors
|
40
|
||
|
Item 2.
|
Unregistered Sales of Equity Securities and Use of Proceeds
|
40
|
||
|
Item 3.
|
Defaults Upon Senior Securities
|
40
|
||
|
Item 4.
|
Mine Safety Disclosures
|
40
|
||
|
Item 5.
|
Other Information
|
40
|
||
|
Item 6.
|
Exhibits
|
40
|
||
|
SIGNATURES
|
41
|
|||
|
April 4, 2026
|
December 31, 2025
|
|||||||
|
Assets
|
||||||||
|
Current assets:
|
||||||||
|
Cash and cash equivalents
|
$
|
|
$
|
|
||||
|
Short-term investments
|
|
|
||||||
|
Accounts receivable, net
|
|
|
||||||
|
Inventories:
|
||||||||
|
Finished goods
|
|
|
||||||
|
Work in process
|
|
|
||||||
|
Raw materials
|
|
|
||||||
|
Total inventories
|
|
|
||||||
|
Prepaid expenses and other current assets
|
|
|
||||||
|
Total current assets
|
|
|
||||||
|
Property and equipment, at cost:
|
||||||||
|
Land
|
|
|
||||||
|
Buildings and improvements
|
|
|
||||||
|
Machinery and equipment
|
|
|
||||||
|
Construction in progress
|
|
|
||||||
|
Allowance for depreciation
|
(
|
)
|
(
|
)
|
||||
|
Property and equipment, net
|
|
|
||||||
|
Right of use assets
|
|
|
||||||
| Deferred income taxes |
||||||||
|
Goodwill
|
|
|
||||||
|
Other intangible assets, net
|
|
|
||||||
|
Other assets
|
|
|
||||||
|
Total assets
|
$
|
|
$
|
|
||||
|
April 4, 2026
|
December 31, 2025
|
|||||||
|
Liabilities and equity
|
||||||||
|
Current liabilities:
|
||||||||
|
Trade accounts payable
|
$
|
|
$
|
|
||||
|
Payroll and related expenses
|
|
|
||||||
|
Lease liabilities
|
|
|
||||||
|
Other accrued expenses
|
|
|
||||||
|
Income taxes
|
|
|
||||||
|
Total current liabilities
|
|
|
||||||
|
Long-term debt less current portion
|
|
|
||||||
|
Deferred income taxes
|
|
|
||||||
|
Long-term lease liabilities
|
|
|
||||||
|
Other liabilities
|
|
|
||||||
|
Accrued pension and other postretirement costs
|
|
|
||||||
|
Total liabilities
|
|
|
||||||
|
Stockholders' equity:
|
||||||||
|
Common stock
|
|
|
||||||
|
Class B convertible common stock
|
|
|
||||||
|
Capital in excess of par value
|
|
|
||||||
|
Retained earnings
|
|
|
||||||
|
Accumulated other comprehensive income
|
|
|
||||||
|
Total equity
|
|
|
||||||
|
Total liabilities and equity
|
$
|
|
$
|
|
||||
|
Fiscal quarters ended
|
||||||||
|
April 4, 2026
|
March 29, 2025
|
|||||||
|
Net revenues
|
$
|
|
$
|
|
||||
|
Costs of products sold
|
|
|
||||||
|
Gross profit
|
|
|
||||||
|
Selling, general, and administrative expenses
|
|
|
||||||
|
Operating income
|
|
|
||||||
|
Other income (expense):
|
||||||||
|
Interest expense
|
(
|
)
|
(
|
)
|
||||
|
Other
|
|
|
||||||
|
Total other income (expense)
|
(
|
)
|
(
|
)
|
||||
|
Income (loss) before taxes
|
|
(
|
)
|
|||||
|
Income tax expense (benefit)
|
|
(
|
)
|
|||||
|
Net earnings (loss)
|
$
|
|
$
|
(
|
)
|
|||
|
Basic earnings (loss) per share
|
$
|
|
$
|
(
|
)
|
|||
|
Diluted earnings (loss) per share
|
$
|
|
$
|
(
|
)
|
|||
|
Weighted average shares outstanding - basic
|
|
|
||||||
|
Weighted average shares outstanding - diluted
|
|
|
||||||
|
Cash dividends per share
|
$
|
|
$
|
|
||||
|
Fiscal quarters ended
|
||||||||
|
April 4, 2026
|
March 29, 2025
|
|||||||
|
Net earnings (loss)
|
$
|
|
$
|
(
|
)
|
|||
|
Other comprehensive income (loss), net of tax
|
||||||||
|
Pension and other post-retirement actuarial items
|
|
|
||||||
|
Foreign currency translation adjustment
|
(
|
)
|
|
|||||
|
Other comprehensive income (loss)
|
(
|
)
|
|
|||||
|
Comprehensive income (loss)
|
$
|
(
|
)
|
$
|
|
|||
|
Three fiscal months ended
|
||||||||
|
April 4, 2026
|
March 29, 2025
|
|||||||
|
Operating activities
|
||||||||
|
Net earnings (loss)
|
$
|
|
$
|
(
|
)
|
|||
|
Adjustments to reconcile net earnings (loss) to net cash provided by operating activities:
|
||||||||
|
Depreciation and amortization
|
|
|
||||||
|
(Gain) loss on disposal of property and equipment
|
(
|
)
|
|
|||||
|
Inventory write-offs for obsolescence
|
|
|
||||||
|
Deferred income taxes
|
|
|
||||||
| Stock compensation expense |
||||||||
|
Other
|
(
|
)
|
(
|
)
|
||||
|
Net change in operating assets and liabilities
|
(
|
)
|
(
|
)
|
||||
|
Net cash provided by operating activities
|
|
|
||||||
|
Investing activities
|
||||||||
|
Capital expenditures
|
(
|
)
|
(
|
)
|
||||
|
Proceeds from sale of property and equipment
|
|
|
||||||
| Purchase of short-term investments | ( |
) | ( |
) | ||||
|
Maturity of short-term investments
|
|
|
||||||
|
Other investing activities
|
|
(
|
)
|
|||||
|
Net cash used in investing activities
|
(
|
)
|
(
|
)
|
||||
|
Financing activities
|
||||||||
|
Net proceeds from revolving credit facility
|
|
|
||||||
|
Dividends paid to common stockholders
|
(
|
)
|
(
|
)
|
||||
|
Dividends paid to Class B common stockholders
|
(
|
)
|
(
|
)
|
||||
|
Repurchase of common stock
|
( |
) | ||||||
|
Cash withholding taxes paid when shares withheld for vested equity awards
|
(
|
)
|
(
|
)
|
||||
|
Net cash provided by financing activities
|
|
|
||||||
|
Effect of exchange rate changes on cash and cash equivalents
|
(
|
)
|
|
|||||
|
Net increase (decrease) in cash and cash equivalents
|
(
|
)
|
|
|||||
|
Cash and cash equivalents at beginning of period
|
|
|
||||||
|
Cash and cash equivalents at end of period
|
$
|
|
$
|
|
||||
|
Common Stock
|
Class B Convertible Common Stock
|
Capital in Excess of Par Value
|
Retained Earnings
|
Treasury Stock |
Accumulated Other Comprehensive Income (Loss)
|
Total Equity
|
||||||||||||||||||||||
|
Balance at December 31, 2024
|
$
|
|
$
|
|
$
|
|
$
|
|
$ | ( |
) |
$
|
(
|
)
|
$
|
|
||||||||||||
|
Net earnings (loss)
|
( |
) | ( |
) | ||||||||||||||||||||||||
|
Other comprehensive income
|
|
|
||||||||||||||||||||||||||
|
Issuance of stock and related tax withholdings for vested restricted stock units (
|
|
( |
) |
|
|
(
|
)
|
|||||||||||||||||||||
|
Dividends declared ($
|
|
(
|
)
|
|
(
|
)
|
||||||||||||||||||||||
|
Stock compensation expense
|
|
|
|
|
||||||||||||||||||||||||
| Repurchase of common stock held in treasury ( |
( |
) | ( |
) | ||||||||||||||||||||||||
|
Balance at March 29, 2025
|
$
|
|
$
|
|
$
|
|
$
|
|
$ | ( |
) |
$
|
(
|
)
|
$
|
|
||||||||||||
| Balance at December 31, 2025 |
$ | $ | $ | $ | $ | $ | $ | |||||||||||||||||||||
|
Net earnings
|
||||||||||||||||||||||||||||
|
Other comprehensive income (loss)
|
|
|
|
|
(
|
)
|
(
|
)
|
||||||||||||||||||||
|
Issuance of stock and related tax withholdings for vested restricted stock units (
|
( |
) | ( |
) | ||||||||||||||||||||||||
|
Dividends declared ($
|
( |
) | ( |
) | ||||||||||||||||||||||||
|
Stock compensation expense
|
|
|
|
|
|
|
||||||||||||||||||||||
| Balance at April 4, 2026 |
$
|
|
$
|
|
$
|
|
$
|
|
$ |
$
|
|
$
|
|
|||||||||||||||
| Expense recorded in 2024 |
$ | |||
| Utilized |
( |
) | ||
| Foreign currency translation |
( |
) | ||
| Balance at December 31, 2024 |
$ | |||
| Utilized |
(
|
)
|
||
| Foreign currency translation |
|
|||
| Balance at December 31, 2025 |
$
|
|
||
| Utilized |
( |
) | ||
| Foreign currency translation |
||||
| Balance at April 4, 2026 | $ |
|
April 4, 2026
|
December 31, 2025
|
|||||||
|
Credit facility
|
$
|
|
$
|
|
||||
| Convertible senior notes, due 2030 | ||||||||
|
Deferred financing costs
|
(
|
)
|
(
|
)
|
||||
|
|
|
|||||||
|
Less current portion
|
|
|
||||||
|
$
|
|
$
|
|
|||||
| 2030 Notes | ||||
|
Issuance date
|
||||
|
Maturity date
|
||||
|
Principal amount as of April 4, 2026
|
$ | |||
|
Cash coupon rate (per annum)
|
% | |||
|
Conversion rate (per $1 principal amount)
|
||||
|
Effective conversion price (per share)
|
$ | |||
|
|
$ | |||
|
Fiscal quarters ended
|
|||||||
|
April 4, 2026
|
March 29, 2025 |
||||||
|
Dividends paid to stockholders
|
$ |
|
$ | ||||
|
Stock repurchases
|
|
||||||
|
Total
|
$ |
|
$ | ||||
|
Fiscal quarters ended
|
||||||||
|
April 4, 2026
|
March 29, 2025
|
|||||||
|
Beginning balance
|
$
|
|
$
|
|
||||
|
Sales allowances
|
|
|
||||||
|
Credits issued
|
(
|
)
|
(
|
)
|
||||
|
Foreign currency
|
(
|
)
|
|
|||||
|
Ending balance
|
$
|
|
$
|
|
||||
|
Pension and
other post-
retirement
actuarial
items
|
Currency
translation
adjustment
|
Total
|
||||||||||
|
Balance at January 1, 2026
|
$
|
(
|
)
|
$
|
|
$
|
|
|||||
|
Other comprehensive income (loss) before reclassifications
|
|
(
|
)
|
$
|
(
|
)
|
||||||
|
Tax effect
|
|
|
$
|
|
||||||||
|
Other comprehensive income (loss) before reclassifications, net of tax
|
|
(
|
)
|
$
|
(
|
)
|
||||||
|
Amounts reclassified out of AOCI
|
|
|
$
|
|
||||||||
|
Tax effect
|
(
|
)
|
|
$
|
(
|
)
|
||||||
|
Amounts reclassified out of AOCI, net of tax
|
|
|
$
|
|
||||||||
|
Net other comprehensive income (loss)
|
$
|
|
$
|
(
|
)
|
$
|
(
|
)
|
||||
|
Balance at April 4, 2026
|
$
|
(
|
)
|
$
|
|
$
|
|
|||||
|
Fiscal quarter ended
April 4, 2026
|
Fiscal quarter ended
March 29, 2025
|
|||||||||||||||
|
U.S. Plans
|
Non-U.S.
Plans
|
U.S. Plans
|
Non-U.S.
Plans
|
|||||||||||||
|
Net service cost
|
$
|
|
$
|
|
$
|
|
$
|
|
||||||||
|
Interest cost
|
|
|
|
|
||||||||||||
|
Expected return on plan assets
|
|
(
|
)
|
|
(
|
)
|
||||||||||
|
Amortization of prior service cost
|
|
|
|
|
||||||||||||
|
Amortization of losses
|
|
|
|
|
||||||||||||
|
Curtailment and settlement losses
|
|
|
|
|
||||||||||||
|
Net periodic benefit cost
|
$
|
|
$
|
|
$
|
|
$
|
|
||||||||
|
Fiscal quarter ended
April 4, 2026
|
Fiscal quarter ended
March 29, 2025
|
|||||||||||||||
|
U.S. Plans
|
Non-U.S.
Plans
|
U.S. Plans
|
Non-U.S.
Plans
|
|||||||||||||
|
Service cost
|
$ |
|
|
$ |
|
|
$ |
|
|
$ |
|
|
||||
|
Interest cost
|
|
|
|
|
||||||||||||
|
Amortization of losses (gains)
|
(
|
)
|
|
(
|
)
|
|
||||||||||
|
Net periodic benefit cost
|
$ |
|
(
|
)
|
$ |
|
|
$ |
|
|
$ |
|
|
|||
|
Fiscal quarters ended
|
||||||||
|
April 4, 2026
|
March 29, 2025
|
|||||||
|
Restricted stock units ("RSUs")
|
$
|
|
$
|
|
||||
|
Phantom stock units
|
|
|
||||||
|
Total
|
$
|
|
$
|
|
||||
|
Unrecognized
Compensation
Cost
|
Weighted
Average
Remaining
Amortization
Periods
|
|||||||
|
Restricted stock units
|
$
|
|
|
|||||
|
Phantom stock units
|
|
n/a
|
||||||
|
Total
|
$
|
|
||||||
|
Number of
RSUs
|
Weighted
Average
Grant-date
Fair Value per
Unit
|
|||||||
|
Outstanding:
|
||||||||
|
January 1, 2026
|
|
$
|
|
|||||
|
Granted
|
|
|
||||||
|
Vested*
|
(
|
)
|
|
|||||
|
Cancelled or forfeited
|
(
|
)
|
|
|||||
|
Outstanding at April 4, 2026
|
|
$
|
|
|||||
|
Expected to vest at April 4, 2026
|
|
|||||||
|
Vesting Date
|
Expected
to Vest
|
Not Expected
to Vest
|
Total
|
|||||||||
|
January 1, 2027
|
||||||||||||
| January 1, 2028 |
||||||||||||
| January 1, 2029 |
|
|
|
|||||||||
|
March 1, 2029
|
||||||||||||
|
Number of
units
|
Grant-date
Fair Value per
Unit
|
|||||||
|
Outstanding:
|
||||||||
|
January 1, 2026
|
|
|||||||
|
Granted
|
|
$
|
|
|||||
|
Dividend equivalents issued
|
|
|||||||
|
Outstanding at April 4, 2026
|
|
|||||||
|
MOSFETs
|
Diodes
|
Optoelectronic
Components
|
Resistors
|
Inductors
|
Capacitors
|
Corporate/
Other
|
Total
|
|||||||||||||||||||||||||
|
Fiscal quarter ended April 4, 2026:
|
||||||||||||||||||||||||||||||||
|
Net revenues
|
$
|
|
$
|
|
$
|
|
$
|
|
$
|
|
$
|
|
$
|
|
||||||||||||||||||
| Cost of products sold (excluding depreciation) |
$ | $ | $ | $ | $ | $ | $ | |||||||||||||||||||||||||
| Depreciation expense in costs of products sold |
||||||||||||||||||||||||||||||||
| Total costs of products sold |
$ | $ | $ | $ | $ | $ | $ | |||||||||||||||||||||||||
| Gross profit |
$ | $ | $ | $ | $ | $ | $ | |||||||||||||||||||||||||
| Segment operating expenses |
$ | $ | $ | $ | $ | $ | $ | |||||||||||||||||||||||||
| Segment operating income |
$ | $ | $ | $ | $ | $ | $ | |||||||||||||||||||||||||
| Total depreciation expense |
$ | $ | $ | $ | $ | $ | $ | $ | ||||||||||||||||||||||||
| Capital expenditures |
||||||||||||||||||||||||||||||||
| Total assets as of April 4, 2026: |
$ | $ | $ | $ | $ | $ | $ | $ | ||||||||||||||||||||||||
|
Fiscal quarter ended March 29, 2025:
|
||||||||||||||||||||||||||||||||
|
Net revenues
|
$
|
|
$
|
|
$
|
|
$
|
|
$
|
|
$
|
|
$
|
|
||||||||||||||||||
| Cost of products sold (excluding depreciation) |
$ | $ | $ | $ | $ | $ | $ | |||||||||||||||||||||||||
| Depreciation expense in cost of products sold |
||||||||||||||||||||||||||||||||
| Total cost of products sold |
$ | $ | $ | $ | $ | $ | $ | |||||||||||||||||||||||||
| Gross profit |
$ | $ | $ | $ | $ | $ | $ | |||||||||||||||||||||||||
| Segment operating expenses |
$ | $ | $ | $ | $ | $ | $ | |||||||||||||||||||||||||
| Segment operating income (loss) |
$ | ( |
) | $ | $ | $ | $ | $ | $ | |||||||||||||||||||||||
| Total depreciation expense |
$ | $ | $ | $ | $ | $ | $ | $ | ||||||||||||||||||||||||
| Capital expenditures |
||||||||||||||||||||||||||||||||
|
Total assets as of March 29, 2025:
|
$
|
|
$
|
|
$ | $ | $ | $ | $ |
$
|
|
|||||||||||||||||||||
|
Fiscal quarters ended
|
||||||||
|
April 4, 2026
|
March 29, 2025
|
|||||||
|
Reconciliation:
|
||||||||
|
Segment Operating Income
|
$
|
|
$
|
|
||||
|
Unallocated Selling, General, and Administrative Expenses
|
(
|
)
|
(
|
)
|
||||
|
Consolidated Operating Income
|
$
|
|
$
|
|
||||
|
Unallocated Other Income (Expense)
|
(
|
)
|
(
|
)
|
||||
|
Consolidated Income (Loss) Before Taxes
|
$
|
|
$
|
(
|
)
|
|||
|
Fiscal quarters ended
|
||||||||
|
April 4, 2026
|
March 29, 2025
|
|||||||
|
Distributors
|
$
|
|
$
|
|
||||
|
OEMs
|
|
|
||||||
|
EMS companies
|
|
|
||||||
|
Total Revenue
|
$
|
|
$
|
|
||||
|
Fiscal quarters ended
|
||||||||
|
April 4, 2026
|
March 29, 2025
|
|||||||
|
Asia
|
$
|
|
$
|
|
||||
|
Europe
|
|
|
||||||
|
Americas
|
|
|
||||||
|
Total Revenue
|
$
|
|
$
|
|
||||
| Fiscal quarters ended |
||||||||
|
April 4, 2026
|
March 29, 2025
|
|||||||
|
Industrial
|
$
|
|
$
|
|
||||
|
Automotive
|
|
|
||||||
|
Military and Aerospace
|
|
|
||||||
|
Healthcare
|
|
|
||||||
|
Other*
|
|
|
||||||
|
Total Revenue
|
$
|
|
$
|
|
||||
|
Fiscal quarters ended
|
||||||||
|
April 4, 2026
|
March 29, 2025
|
|||||||
|
Numerator:
|
||||||||
|
Net earnings (loss)
|
$
|
|
$
|
(
|
)
|
|||
|
Denominator:
|
||||||||
|
Denominator for basic earnings (loss) per share:
|
||||||||
|
Weighted average shares
|
|
|
||||||
|
Outstanding phantom stock units
|
|
|
||||||
|
Adjusted weighted average shares - basic
|
|
|
||||||
|
Effect of dilutive securities:
|
||||||||
|
Restricted stock units
|
|
|
||||||
|
Dilutive potential common shares
|
|
|
||||||
|
Denominator for diluted earnings (loss) per share:
|
||||||||
|
Adjusted weighted average shares - diluted
|
|
|
||||||
|
Basic earnings (loss) per share
|
$
|
|
$
|
(
|
)
|
|||
|
Diluted earnings (loss) per share
|
$
|
|
$
|
(
|
)
|
|||
|
Fiscal quarters ended
|
||||||||
|
April 4, 2026
|
March 29, 2025
|
|||||||
|
Restricted stock units
|
|
|
||||||
|
Total
Fair Value
|
Level 1
|
Level 2
|
Level 3
|
|||||||||||||
| April 4, 2026 |
||||||||||||||||
|
Assets:
|
||||||||||||||||
|
Assets held in rabbi trusts
|
$
|
$
|
$
|
$
|
||||||||||||
|
Available for sale securities
|
$
|
|||||||||||||||
|
$
|
$
|
$
|
$
|
|||||||||||||
| Liability: |
||||||||||||||||
| Acquisitions contingent consideration |
$ | $ | $ | $ | ||||||||||||
| December 31, 2025
|
||||||||||||||||
|
Assets:
|
||||||||||||||||
|
Assets held in rabbi trusts
|
$
|
$
|
$
|
$
|
||||||||||||
|
Available for sale securities
|
$
|
|||||||||||||||
|
$
|
$
|
$
|
$
|
|||||||||||||
| Liability: |
||||||||||||||||
| Acquisitions contingent consideration |
$ | $ | $ | $ | ||||||||||||
| Item 2. |
Management’s Discussion and Analysis of Financial Condition and Results of Operations
|
|
Fiscal quarters ended
|
||||||||||||
|
April 4, 2026
|
December 31, 2025
|
March 29, 2025
|
||||||||||
|
Net cash provided by continuing operating activities
|
$
|
63,669
|
$
|
149,362
|
$
|
16,098
|
||||||
|
Proceeds from sale of property and equipment
|
66
|
308
|
279
|
|||||||||
|
Less: Capital expenditures
|
(110,661
|
)
|
(94,802
|
)
|
(61,569
|
)
|
||||||
|
Free cash
|
$
|
(46,926
|
)
|
$
|
54,868
|
$
|
(45,192
|
)
|
||||
| Fiscal quarters ended |
||||||||
|
April 4, 2026
|
March 29, 2025 |
|||||||
|
Dividends paid to stockholders
|
$ |
|
13,611
|
$ | 13,562 | |||
|
Stock repurchases
|
-
|
12,538 | ||||||
|
Total
|
$ |
|
13,611
|
$ | 26,100 | |||
|
1st Quarter 2025
|
2nd Quarter 2025
|
3rd Quarter 2025
|
4th Quarter 2025
|
1st Quarter 2026
|
||||||||||||||||
|
Net revenues
|
$
|
715,236
|
$
|
762,250
|
$
|
790,640
|
$
|
800,922
|
$
|
839,242
|
||||||||||
|
Gross profit margin
|
19.0
|
%
|
19.5
|
%
|
19.5
|
%
|
19.6
|
%
|
21.0
|
%
|
||||||||||
|
Operating margin(1)
|
0.1
|
%
|
2.9
|
%
|
2.4
|
%
|
1.8
|
%
|
2.6
|
%
|
||||||||||
|
End-of-period backlog
|
$
|
1,124,300
|
$
|
1,174,900
|
$
|
1,152,700
|
$
|
1,314,100
|
$
|
1,592,300
|
||||||||||
|
Book-to-bill ratio
|
1.08
|
1.02
|
0.97
|
1.20
|
1.34
|
|||||||||||||||
|
Inventory turnover
|
3.3
|
3.3
|
3.3
|
3.4
|
3.4
|
|||||||||||||||
|
Change in ASP vs. prior quarter
|
(1.3
|
)%
|
0.0
|
%
|
(0.3
|
)%
|
(0.3
|
)%
|
(1.1
|
)%
|
||||||||||
(1) Operating margin for the second fiscal quarter of 2025 includes an $11.3 million gain recognized upon the favorable resolution of a contingency.
|
1st Quarter 2025
|
2nd Quarter 2025
|
3rd Quarter 2025
|
4th Quarter 2025
|
1st Quarter 2026
|
||||||||||||||||
|
MOSFETs
|
||||||||||||||||||||
|
Net revenues
|
$
|
142,113
|
$
|
148,633
|
$
|
167,133
|
$
|
172,584
|
$
|
173,991
|
||||||||||
|
Book-to-bill ratio
|
1.32
|
1.00
|
0.86
|
1.48
|
1.57
|
|||||||||||||||
|
Gross profit margin
|
8.2
|
%
|
6.3
|
%
|
10.1
|
%
|
13.8
|
%
|
12.9
|
%
|
||||||||||
|
Segment operating margin
|
(6.1
|
)%
|
(9.7
|
)%
|
(3.8
|
)%
|
(0.5
|
)%
|
0.8
|
%
|
||||||||||
|
Diodes
|
||||||||||||||||||||
|
Net revenues
|
$
|
140,963
|
$
|
147,942
|
$
|
149,628
|
$
|
154,224
|
$
|
163,669
|
||||||||||
|
Book-to-bill ratio
|
0.99
|
0.93
|
1.07
|
1.09
|
1.35
|
|||||||||||||||
|
Gross profit margin
|
19.9
|
%
|
20.0
|
%
|
20.3
|
%
|
20.3
|
%
|
21.3
|
%
|
||||||||||
|
Segment operating margin
|
15.0
|
%
|
15.0
|
%
|
15.2
|
%
|
15.3
|
%
|
15.8
|
%
|
||||||||||
|
Optoelectronic Components
|
||||||||||||||||||||
|
Net revenues
|
$
|
51,168
|
$
|
54,119
|
$
|
55,590
|
$
|
55,674
|
$
|
58,875
|
||||||||||
|
Book-to-bill ratio
|
0.90
|
1.05
|
0.93
|
1.12
|
1.48
|
|||||||||||||||
|
Gross profit margin
|
20.9
|
%
|
23.2
|
%
|
22.9
|
%
|
15.0
|
%
|
18.6
|
%
|
||||||||||
|
Segment operating margin
|
10.6
|
%
|
12.6
|
%
|
12.9
|
%
|
4.5
|
%
|
8.0
|
%
|
||||||||||
|
Resistors
|
||||||||||||||||||||
|
Net revenues
|
$
|
179,500
|
$
|
194,769
|
$
|
195,707
|
$
|
189,367
|
$
|
203,743
|
||||||||||
|
Book-to-bill ratio
|
1.00
|
0.91
|
0.92
|
1.05
|
1.26
|
|||||||||||||||
|
Gross profit margin
|
22.5
|
%
|
22.8
|
%
|
20.1
|
%
|
19.4
|
%
|
22.0
|
%
|
||||||||||
|
Segment operating margin
|
17.4
|
%
|
17.9
|
%
|
15.3
|
%
|
14.3
|
%
|
16.8
|
%
|
||||||||||
|
Inductors
|
||||||||||||||||||||
|
Net revenues
|
$
|
84,121
|
$
|
95,675
|
$
|
91,990
|
$
|
92,588
|
$
|
92,225
|
||||||||||
|
Book-to-bill ratio
|
1.02
|
0.91
|
0.99
|
1.07
|
1.31
|
|||||||||||||||
|
Gross profit margin
|
20.9
|
%
|
28.0
|
%
|
30.7
|
%
|
29.8
|
%
|
31.8
|
%
|
||||||||||
|
Segment operating margin
|
16.5
|
%
|
24.0
|
%
|
26.6
|
%
|
25.4
|
%
|
27.4
|
%
|
||||||||||
|
Capacitors
|
||||||||||||||||||||
|
Net revenues
|
$
|
117,371
|
$
|
121,112
|
$
|
130,592
|
$
|
136,485
|
$
|
146,739
|
||||||||||
|
Book-to-bill ratio
|
1.13
|
1.40
|
1.07
|
1.30
|
1.13
|
|||||||||||||||
|
Gross profit margin
|
23.2
|
%
|
21.5
|
%
|
20.1
|
%
|
21.3
|
%
|
23.4
|
%
|
||||||||||
|
Segment operating margin
|
17.5
|
%
|
16.3
|
%
|
15.2
|
%
|
16.6
|
%
|
18.7
|
%
|
||||||||||
|
Fiscal quarters ended
|
||||||||||||
|
April 4, 2026
|
December 31, 2025
|
March 29, 2025
|
||||||||||
|
Cost of products sold
|
79.0
|
%
|
80.4
|
%
|
81.0
|
%
|
||||||
|
Gross profit
|
21.0
|
%
|
19.6
|
%
|
19.0
|
%
|
||||||
|
Selling, general & administrative expenses
|
18.4
|
%
|
17.7
|
%
|
18.8
|
%
|
||||||
|
Operating income
|
2.6
|
%
|
1.8
|
%
|
0.1
|
%
|
||||||
|
Income (loss) before taxes
|
1.5
|
%
|
0.7
|
%
|
(0.6
|
)%
|
||||||
|
Net earnings (loss)
|
0.9
|
%
|
0.1
|
%
|
(0.6
|
)%
|
||||||
|
________
|
||||||||||||
|
Effective tax rate
|
44.3
|
%
|
82.3
|
%
|
3.2
|
%
|
||||||
|
Fiscal quarters ended
|
||||||||||||
|
April 4, 2026
|
December 31, 2025
|
March 29, 2025
|
||||||||||
|
Net revenues
|
$ |
|
839,242
|
$ |
|
800,922
|
$ |
|
715,236
|
|||
|
Fiscal quarter ended
April 4, 2026
|
||||||||||
|
Change in net revenues
|
% change
|
|||||||||
|
December 31, 2025
|
$ |
38,320
|
4.8
|
%
|
||||||
|
March 29, 2025
|
$ |
124,006
|
17.3
|
%
|
||||||
|
vs. Prior Quarter
|
vs. Prior Year Quarter
|
|||||||
|
Change attributable to:
|
||||||||
|
Increase in volume
|
5.8
|
%
|
14.4
|
%
|
||||
|
Decrease in average selling prices
|
(1.1
|
)%
|
(0.8
|
)%
|
||||
|
Foreign currency effects
|
0.2
|
%
|
3.9
|
%
|
||||
|
Other
|
(0.1
|
)%
|
(0.2
|
)%
|
||||
|
Net change
|
4.8
|
%
|
17.3
|
%
|
||||
|
Fiscal quarters ended
|
||||||||||||
|
April 4, 2026
|
December 31, 2025
|
March 29, 2025
|
||||||||||
|
Net revenues
|
$
|
173,991
|
$
|
172,584
|
$
|
142,113
|
||||||
| Gross profit margin |
12.9 | % | 13.8 | % | 8.2 | % | ||||||
|
Segment operating margin
|
0.8
|
%
|
(0.5
|
)%
|
(6.1
|
)%
|
||||||
|
Fiscal quarter ended
April 4, 2026
|
||||||||||
|
Change in net revenues
|
% change
|
|||||||||
|
December 31, 2025
|
$ |
1,407
|
0.8
|
%
|
||||||
|
March 29, 2025
|
$ |
31,878
|
22.4
|
%
|
||||||
|
vs. Prior Quarter
|
vs. Prior Year Quarter
|
|||||||
|
Change attributable to:
|
||||||||
|
Increase in volume
|
1.4
|
%
|
26.8
|
%
|
||||
|
Decrease in average selling prices
|
(0.8
|
)%
|
(5.2
|
)%
|
||||
|
Foreign currency effects
|
0.1
|
%
|
2.3
|
%
|
||||
|
Other
|
0.1
|
%
|
(1.5
|
)%
|
||||
|
Net change
|
0.8
|
%
|
22.4
|
%
|
||||
|
Fiscal quarters ended
|
||||||||||||
|
April 4, 2026
|
December 31, 2025
|
March 29, 2025
|
||||||||||
|
Net revenues
|
$ |
|
163,669
|
$ |
|
154,224
|
$ |
|
140,963
|
|||
| Gross profit margin |
21.3 | % | 20.3 | % | 19.9 | % | ||||||
|
Segment operating margin
|
15.8
|
%
|
15.3
|
%
|
15.0
|
%
|
||||||
|
Fiscal quarter ended
April 4, 2026
|
||||||||||
|
Change in net revenues
|
% change
|
|||||||||
|
December 31, 2025
|
$ |
|
9,445
|
6.1
|
%
|
|||||
|
March 29, 2025
|
$ |
|
22,706
|
16.1
|
%
|
|||||
|
vs. Prior Quarter
|
vs. Prior Year Quarter
|
|||||||
|
Change attributable to:
|
||||||||
|
Increase in volume
|
8.4
|
%
|
14.4
|
%
|
||||
|
Decrease in average selling prices
|
(2.1
|
)%
|
(1.1
|
)%
|
||||
|
Foreign currency effects
|
0.1
|
%
|
3.2
|
%
|
||||
|
Other
|
(0.3
|
)%
|
(0.4
|
)%
|
||||
|
Net change
|
6.1
|
%
|
16.1
|
%
|
||||
|
Fiscal quarters ended
|
||||||||||||
|
April 4, 2026
|
December 31, 2025
|
March 29, 2025
|
||||||||||
|
Net revenues
|
$ |
|
58,875
|
$ |
|
55,674
|
$ |
|
51,168
|
|||
|
Gross profit margin
|
18.6
|
%
|
15.0
|
%
|
20.9
|
%
|
||||||
|
Segment operating margin
|
8.0
|
%
|
4.5
|
%
|
10.6
|
%
|
||||||
|
Fiscal quarter ended
April 4, 2026
|
||||||||||
|
Change in net revenues
|
% change
|
|||||||||
|
December 31, 2025
|
$ |
|
3,201
|
5.7
|
%
|
|||||
|
March 29, 2025
|
$ |
|
7,707
|
15.1
|
%
|
|||||
|
vs. Prior Quarter
|
vs. Prior Year Quarter
|
|||||||
|
Change attributable to:
|
||||||||
|
Increase in volume
|
6.6
|
%
|
12.0
|
%
|
||||
|
Decrease in average selling prices
|
(1.1
|
)%
|
(2.1
|
)%
|
||||
|
Foreign currency effects
|
0.3
|
%
|
5.6
|
%
|
||||
|
Other
|
(0.1
|
)%
|
(0.4
|
)%
|
||||
|
Net change
|
5.7
|
%
|
15.1
|
%
|
||||
Segment operating margin increased versus the prior fiscal quarter, but decreased versus the prior year quarter. The changes are primarily due to changes in gross profit.
|
Fiscal quarters ended
|
||||||||||||
|
April 4, 2026
|
December 31, 2025
|
March 29, 2025
|
||||||||||
|
Net revenues
|
$ |
|
203,743
|
$ |
|
189,367
|
$ |
|
179,500
|
|||
| Gross profit margin |
22.0 | % | 19.4 | % | 22.5 | % | ||||||
|
Segment operating margin
|
16.8
|
%
|
14.3
|
%
|
17.4
|
%
|
||||||
|
Fiscal quarter ended
April 4, 2026
|
||||||||||
|
Change in net revenues
|
% change
|
|||||||||
|
December 31, 2025
|
$ |
|
14,376
|
7.6
|
%
|
|||||
|
March 29, 2025
|
$ |
|
24,243
|
13.5
|
%
|
|||||
|
vs. Prior Quarter
|
vs. Prior Year Quarter
|
|||||||
|
Change attributable to:
|
||||||||
|
Increase in volume
|
7.7
|
%
|
6.5
|
%
|
||||
|
Change in average selling prices
|
(0.4
|
)%
|
2.2
|
%
|
||||
|
Foreign currency effects
|
0.2
|
%
|
4.6
|
%
|
||||
|
Other
|
0.1
|
%
|
0.2
|
%
|
||||
|
Net change
|
7.6
|
%
|
13.5
|
%
|
||||
|
Fiscal quarters ended
|
||||||||||||
|
April 4, 2026
|
December 31, 2025
|
March 29, 2025
|
||||||||||
|
Net revenues
|
$ |
|
92,225
|
$ |
|
92,588
|
$ |
|
84,121
|
|||
| Gross profit margin |
31.8 | % | 29.8 | % | 20.9 | % | ||||||
|
Segment operating margin
|
27.4
|
%
|
25.4
|
%
|
16.5
|
%
|
||||||
|
Fiscal quarter ended
April 4, 2026
|
||||||||||
|
Change in net revenues
|
% change
|
|||||||||
|
December 31, 2025
|
$ |
|
(363
|
)
|
(0.4
|
)%
|
||||
|
March 29, 2025
|
$ |
|
8,104
|
9.6
|
%
|
|||||
|
vs. Prior Quarter
|
vs. Prior Year Quarter
|
|||||||
|
Change attributable to:
|
||||||||
|
Increase in volume
|
2.2
|
%
|
9.0
|
%
|
||||
|
Decrease in average selling prices
|
(2.6
|
)%
|
(1.2
|
)%
|
||||
|
Foreign currency effects
|
0.1
|
%
|
1.9
|
%
|
||||
|
Other
|
(0.1
|
)%
|
(0.1
|
)%
|
||||
|
Net change
|
(0.4
|
)%
|
9.6
|
%
|
||||
|
Fiscal quarters ended
|
||||||||||||
|
April 4, 2026
|
December 31, 2025
|
March 29, 2025
|
||||||||||
|
Net revenues
|
$ |
|
146,739
|
$ |
|
136,485
|
$ |
|
117,371
|
|||
| Gross profit margin |
23.4 | % | 21.3 | % | 23.2 | % | ||||||
|
Segment operating margin
|
18.7 | % | 16.6 | % | 17.5 | % | ||||||
|
Fiscal quarter ended
April 4, 2026
|
||||||||||
|
Change in net revenues
|
% change
|
|||||||||
|
December 31, 2025
|
$ |
|
10,254
|
7.5
|
%
|
|||||
|
March 29, 2025
|
$ |
|
29,368
|
25.0
|
%
|
|||||
|
vs. Prior
Quarter
|
vs. Prior Year Quarter
|
|||||||
|
Change attributable to:
|
||||||||
|
Increase in volume
|
7.7
|
%
|
16.4
|
%
|
||||
|
Change in average selling prices
|
(0.2
|
)%
|
1.8
|
%
|
||||
|
Foreign currency effects
|
0.3
|
%
|
6.6
|
%
|
||||
|
Other
|
(0.3
|
)%
|
0.2
|
%
|
||||
|
Net change
|
7.5
|
%
|
25.0
|
%
|
||||
|
Fiscal quarters ended
|
||||||||||||
|
April 4, 2026
|
December 31, 2025
|
March 29, 2025
|
||||||||||
|
Total SG&A expenses
|
$ |
|
154,488
|
$ |
|
141,999
|
$ |
|
134,739
|
|||
|
as a percentage of revenues
|
18.4
|
%
|
17.7
|
%
|
18.8
|
%
|
||||||
|
Fiscal quarters ended
|
||||||||||||
|
April 4, 2026
|
December 31, 2025
|
Change
|
||||||||||
|
Foreign exchange loss
|
$
|
(586
|
)
|
$
|
(506
|
)
|
$
|
(80
|
)
|
|||
|
Interest income
|
3,038
|
2,753
|
285
|
|||||||||
|
Other components of net periodic pension expense
|
(1,919
|
)
|
(2,442
|
)
|
523
|
|||||||
|
Investment income (expense)
|
170
|
(111
|
)
|
281
|
||||||||
|
Other
|
(2
|
)
|
843
|
(845
|
)
|
|||||||
|
$
|
701
|
$
|
537
|
$
|
164
|
|||||||
|
Fiscal quarters ended
|
||||||||||||
|
April 4, 2026
|
March 29, 2025
|
Change
|
||||||||||
|
Foreign exchange gain (loss)
|
$
|
(586
|
)
|
$
|
1,329
|
$
|
(1,915
|
)
|
||||
|
Interest income
|
3,038
|
3,877
|
(839
|
)
|
||||||||
|
Other components of net period pension expense
|
(1,919
|
)
|
(1,697
|
)
|
(222
|
)
|
||||||
|
Investment income
|
170
|
261
|
(91
|
)
|
||||||||
|
Other
|
(2
|
)
|
(23
|
)
|
21
|
|||||||
|
$
|
701
|
$
|
3,747
|
$
|
(3,046
|
)
|
||||||
|
Fiscal quarters ended
|
||||||||||||||||||||
|
1st Quarter 2025
|
2nd Quarter 2025
|
3rd Quarter 2025
|
4th Quarter 2025
|
1st Quarter 2026
|
||||||||||||||||
|
Days sales outstanding ("DSO") (a)
|
53
|
53
|
53
|
48
|
41
|
|||||||||||||||
|
Days inventory outstanding ("DIO") (b)
|
110
|
109
|
108
|
107
|
106
|
|||||||||||||||
|
Days payable outstanding ("DPO") (c)
|
(34
|
)
|
(32
|
)
|
(31
|
)
|
(30
|
)
|
(31
|
)
|
||||||||||
|
Cash conversion cycle
|
129
|
130
|
130
|
125
|
116
|
|||||||||||||||
|
April 4, 2026
|
December 31, 2025
|
|||||||
|
Credit facility
|
$
|
250,000
|
$
|
219,000
|
||||
|
Convertible senior notes, due 2030
|
750,000
|
750,000
|
||||||
|
Deferred financing costs
|
(16,910
|
)
|
(18,107
|
)
|
||||
|
Total debt
|
983,090 | 950,893 | ||||||
|
Cash and cash equivalents
|
479,357 | 514,966 | ||||||
|
Short-term investments
|
191 | 265 | ||||||
|
Net cash and short-term investments (debt)
|
$ | (503,542 | ) | (435,662 | ) | |||
| Item 3. |
Quantitative and Qualitative Disclosures About Market Risk
|
| Item 4. |
Controls and Procedures
|
| Item 1. |
Legal Proceedings
|
| Item 1A. |
Risk Factors
|
| Item 2. |
Unregistered
Sales of Equity Securities and Use of Proceeds
|
| Item 3. |
Defaults Upon
Senior Securities
|
| Item 4. |
Mine Safety
Disclosures
|
| Item 5. |
Other Information
|
| Item 6. |
Exhibits
|
|
31.1
|
Certification pursuant to Rule
13a-14(a) or 15d-14(a) under the Securities Exchange Act of 1934, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 - Joel Smejkal, Chief Executive Officer.
|
|
31.2
|
Certification pursuant to Rule
13a-14(a) or 15d-14(a) under the Securities Exchange Act of 1934, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 - David E. McConnell, Chief Financial Officer.
|
|
32.1
|
Certification Pursuant to 18 U.S.C.
Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 – Joel Smejkal, Chief Executive Officer.
|
|
32.2
|
Certification Pursuant to 18 U.S.C.
Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 – David E. McConnell, Chief Financial Officer.
|
|
101
|
Interactive Data File (Quarterly Report on Form 10-Q, for the quarterly period ended April 4, 2026, furnished in iXBRL (Inline eXtensible Business
Reporting Language)).
|
|
104
|
Cover Page Interactive Data File (formatted as Inline eXtensible Business Reporting Language and contained in Exhibit 101)
|
|
VISHAY INTERTECHNOLOGY, INC.
|
||
|
/s/ David E. McConnell
|
||
|
David E. McConnell
|
||
|
Executive Vice President and Chief Financial Officer
|
||
|
(as a duly authorized officer and principal financial officer)
|
||
|
/s/ David L. Tomlinson
|
||
|
David L. Tomlinson
|
||
|
Senior Vice President - Chief Accounting Officer
|
||
|
(as a duly authorized officer and principal accounting officer)
|
||